Madrigal Pharmaceuticals Appoints John C. Reed to Board of Directors

Bitget2026/11/03 12:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Madrigal Pharmaceuticals appointed John C. Reed to its board in August 2026.
Reed serves as Johnson & Johnson’s executive vice president for Innovative Medicine R&D. He previously held executive leadership roles at Sanofi and Roche.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Madrigal Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030700PRIMZONEFULLFEED9868394) on November 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Madrigal Pharmaceuticals Appoints John C. Reed to Board of Directors

You may also like

Crypto prices